| 1 | [SID56462800] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56462800 | | CID | 3893 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID56462800] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56462800 | | CID | 3893 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 3 | [SID103329807] | Unspecified | LD50 | 10 | Cytotoxicity against mouse RAW264.7 cells [AID627981, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | LD50 | 10 [uM] | | BioAssay | Cytotoxicity against mouse RAW264.7 cells | | AID | 627981 | | BioAssay type | Literature | | Target | | | PubMed | 21903399 | | Data Table |  |
|
| 4 | [SID103329807] | Unspecified | MIC | 62.5 | Antitubercular activity against Mycobacterium tuberculosis 90-221387 [AID403754, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | MIC | 62.5 [uM] | | BioAssay | Antitubercular activity against Mycobacterium tuberculosis 90-221387 | | AID | 403754 | | BioAssay type | Literature | | Target | | | PubMed | 16180806 | | Data Table |  |
|
| 5 | [SID103329807] | Unspecified | IC50 | 1980 | Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined. [AID40623, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | IC50 | 1980 [uM] | | BioAssay | Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined. | | AID | 40623 | | BioAssay type | Literature | | Target | | | PubMed | 6802973 | | Data Table |  |
|
| 6 | [SID103329807] | Unspecified | IC50 | 1995.26 | Inhibition of Bacillus subtilis spore germination, activity is expressed as log of the reciprocal of Casida's I50 value. [AID40935, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | IC50 | 1995.26 [uM] | | BioAssay | Inhibition of Bacillus subtilis spore germination, activity is expressed as log of the reciprocal of Casida's I50 value. | | AID | 40935 | | BioAssay type | Literature | | Target | | | PubMed | 6887198 | | Data Table |  |
|
| 7 | [SID103329807] | Unspecified | IC50 | 1995.26 | Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I50 [AID40936, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | IC50 | 1995.26 [uM] | | BioAssay | Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I50 | | AID | 40936 | | BioAssay type | Literature | | Target | | | PubMed | 6802973 | | Data Table |  |
|
| 8 | [SID103329807] | Unspecified | | | Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Pseudomonas aeruginosa at pH 7.0, concentration 610 ppm [AID164418, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Pseudomonas aeruginosa at pH 7.0, concentration 610 ppm | | AID | 164418 | | BioAssay type | Literature | | Target | | | PubMed | 7381846 | | Data Table |  |
|
| 9 | [SID103329807] | Unspecified | | | Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Staphylococcus aureus at pH 7.0, concentration 610 ppm [AID207085, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Staphylococcus aureus at pH 7.0, concentration 610 ppm | | AID | 207085 | | BioAssay type | Literature | | Target | | | PubMed | 7381846 | | Data Table |  |
|
| 10 | [SID103329807] | Unspecified | | | Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Streptococcus pyogenes at pH 7.0, concentration 610 ppm [AID210082, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Streptococcus pyogenes at pH 7.0, concentration 610 ppm | | AID | 210082 | | BioAssay type | Literature | | Target | | | PubMed | 7381846 | | Data Table |  |
|
| 11 | [SID103329807] | Unspecified | | | Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method [AID332912, Type: other] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method | | AID | 332912 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID103329807] | Unspecified | | | Antimicrobial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial broth dilution method [AID334989, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial broth dilution method | | AID | 334989 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID103329807] | Unspecified | | | Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial broth dilution method [AID334990, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial broth dilution method | | AID | 334990 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID103329807] | Unspecified | | | Antimicrobial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial broth dilution method [AID334991, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial broth dilution method | | AID | 334991 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID103329807] | Unspecified | | | Antimicrobial activity against Staphylococcus aureus ATCC 12598 after 2 days by twofold serial broth dilution method [AID334992, Type: other] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Staphylococcus aureus ATCC 12598 after 2 days by twofold serial broth dilution method | | AID | 334992 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID103329807] | Unspecified | | | Antimicrobial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial broth dilution method [AID334993, Type: other] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial broth dilution method | | AID | 334993 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID103329807] | Unspecified | | | Antimicrobial activity against Escherichia coli ATCC 9637 after 2 days by twofold serial broth dilution method [AID334994, Type: other] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Escherichia coli ATCC 9637 after 2 days by twofold serial broth dilution method | | AID | 334994 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID103329807] | Unspecified | | | Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by twofold serial broth dilution method [AID334995, Type: other] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by twofold serial broth dilution method | | AID | 334995 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID103329807] | Unspecified | | | Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 2 days by twofold serial broth dilution method [AID334996, Type: other] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 2 days by twofold serial broth dilution method | | AID | 334996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID103329807] | Unspecified | | | Antimicrobial activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by twofold serial broth dilution method [AID334997, Type: other] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by twofold serial broth dilution method | | AID | 334997 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID103329807] | Unspecified | | | Antimicrobial activity against Candida utilis ATCC 9226 after 2 days by twofold serial broth dilution method [AID334998, Type: other] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Candida utilis ATCC 9226 after 2 days by twofold serial broth dilution method | | AID | 334998 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID103329807] | Unspecified | | | Antimicrobial activity against Pityrosporum ovale ATCC 14521 by twofold serial broth dilution method [AID334999, Type: other] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Pityrosporum ovale ATCC 14521 by twofold serial broth dilution method | | AID | 334999 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID103329807] | Unspecified | | | Antimicrobial activity against Penicillium chrysogenum ATCC 10106 after 5 days by twofold serial broth dilution method [AID335000, Type: other] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Penicillium chrysogenum ATCC 10106 after 5 days by twofold serial broth dilution method | | AID | 335000 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID103329807] | Unspecified | | | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by macrobroth dilution method [AID390912, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by macrobroth dilution method | | AID | 390912 | | BioAssay type | Literature | | Target | | | PubMed | 18778047 | | Data Table |  |
|
| 25 | [SID103329807] | Unspecified | | | Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by macrobroth dilution method [AID390920, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by macrobroth dilution method | | AID | 390920 | | BioAssay type | Literature | | Target | | | PubMed | 18778047 | | Data Table |  |
|
| 26 | [SID103329807] | Unspecified | | | Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay [AID492140, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay | | AID | 492140 | | BioAssay type | Literature | | Target | | | PubMed | 20565070 | | Data Table |  |
|
| 27 | [SID103329807] | Unspecified | | | Antibacterial activity against Staphylococcus aureus by broth microdilution method [AID597407, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antibacterial activity against Staphylococcus aureus by broth microdilution method | | AID | 597407 | | BioAssay type | Literature | | Target | | | PubMed | 21493076 | | Data Table |  |
|
| 28 | [SID103329807] | Unspecified | | | Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method [AID597408, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method | | AID | 597408 | | BioAssay type | Literature | | Target | | | PubMed | 21493076 | | Data Table |  |
|
| 29 | [SID17388953] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17388953 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID17389665] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17389665 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID103329807] | Unspecified | | | Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP2E1 [AID589037, Type: other] | Cytochrome P450 2E1 [gi:117250] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP2E1 | | AID | 589037 | | BioAssay type | other | | Target | Cytochrome P450 2E1 [gi:117250] | | PubMed | | | Data Table |  |
|
| 32 | [SID103329807] | Unspecified | | | Dissociation constant (pKa) [AID25611, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Dissociation constant (pKa) | | AID | 25611 | | BioAssay type | Literature | | Target | | | PubMed | 6802973 | | Data Table |  |
|
| 33 | [SID103329807] | Unspecified | | | Partition coefficient (logD7.2) [AID26261, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logD7.2) | | AID | 26261 | | BioAssay type | Literature | | Target | | | PubMed | 6802973 | | Data Table |  |
|
| 34 | [SID103329807] | Unspecified | | | Partition coefficient (logP) [AID26793, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) | | AID | 26793 | | BioAssay type | Literature | | Target | | | PubMed | 6802973 | | Data Table |  |
|
| 35 | [SID103329807] | Unspecified | | | Cytotoxicity against mouse RAW264.7 cells at 5 uM [AID627980, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against mouse RAW264.7 cells at 5 uM | | AID | 627980 | | BioAssay type | Literature | | Target | | | PubMed | 21903399 | | Data Table |  |
|
| 36 | [SID56462800] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56462800 | | CID | 3893 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID56462800] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56462800 | | CID | 3893 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 38 | [SID103329807] | Unspecified | | | Specific activity of expressed human recombinant UGT1A10 [AID624613, Type: Literature] | UDP-glucuronosyltransferase 1-10 [gi:29839636] |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Specific activity of expressed human recombinant UGT1A10 | | AID | 624613 | | BioAssay type | Literature | | Target | UDP-glucuronosyltransferase 1-10 [gi:29839636] | | PubMed | 10836148 | | Data Table |  |
|
| 39 | [SID103329807] | Unspecified | | | Specific activity of expressed human recombinant UGT1A8 [AID624611, Type: Literature] | UDP-glucuronosyltransferase 1-8 [gi:29839637] |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Specific activity of expressed human recombinant UGT1A8 | | AID | 624611 | | BioAssay type | Literature | | Target | UDP-glucuronosyltransferase 1-8 [gi:29839637] | | PubMed | 10836148 | | Data Table |  |
|
| 40 | [SID103329807] | Unspecified | | | Specific activity of expressed human recombinant UGT1A3 [AID624607, Type: Literature] | UDP-glucuronosyltransferase 1-4 [gi:136731] |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103329807 | | CID | 3893 | | Outcome | Unspecified | | BioAssay | Specific activity of expressed human recombinant UGT1A3 | | AID | 624607 | | BioAssay type | Literature | | Target | UDP-glucuronosyltransferase 1-4 [gi:136731] | | PubMed | 10836148 | | Data Table |  |
|
| 41 | [SID17389665] | Inactive | Potency | 14.1254 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17389665 | | CID | 3893 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 42 | [SID17389665] | Inactive | Potency | 14.1254 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17389665 | | CID | 3893 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 43 | [SID17389665] | Inactive | Potency | 29.8493 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17389665 | | CID | 3893 | | Outcome | Inactive | | Potency | 29.8493 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 44 | [SID17389665] | Inactive | Potency | 29.8493 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17389665 | | CID | 3893 | | Outcome | Inactive | | Potency | 29.8493 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 45 | [SID17389665] | Inactive | Potency | 29.8493 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17389665 | | CID | 3893 | | Outcome | Inactive | | Potency | 29.8493 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 46 | [SID17389665] | Inactive | Potency | 29.8493 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17389665 | | CID | 3893 | | Outcome | Inactive | | Potency | 29.8493 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 47 | [SID17389665] | Inactive | Potency | 29.8493 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17389665 | | CID | 3893 | | Outcome | Inactive | | Potency | 29.8493 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 48 | [SID56462800] | Inactive | Potency | 31.6228 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56462800 | | CID | 3893 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 49 | [SID17388953] | Inactive | Potency | 66.8242 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17388953 | | CID | 3893 | | Outcome | Inactive | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 50 | [SID17388953] | Inactive | Potency | 66.8242 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17388953 | | CID | 3893 | | Outcome | Inactive | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|